Podcast, News & Publications

Oak Tree with Twisted Branches

Peace in strength.  Like the mighty oak that has survived some 600 years in what is now my back yard, we engage with experience and resilience.  Whether the winds blow hard or the sun shines bright, we go on, deeply rooted and stretching for the heavens.

Strength in peace.  Many challenges of the world, and Pharmaceutical R&D, grow out of mere misunderstandings.  We seek to enhance mutual understanding and peaceful cooperation toward shared objectives.

- Peace and Strength by Kevin Freiert

Salem Oaks Presents: a podcast sharing the human stories behind the medicines

Episode 6: Robert Weker Against All Odds

Feb 11, 2020

Rob Weker’s story is remarkable for many reasons. First and foremost, he has beaten cancer.  Not once. Not twice. But three times.  Getting the third diagnosis, this time it was pancreatic cancer, really got his attention. Only 7% of pancreatic patients live beyond 5-years. I met Rob at last year’s Patients…

Read More

Carol Marzetta: Living to Help Other People

Jan 14, 2020

This month listen to Dr. Carol Marzetta talk about how the urge to help other people has shaped her career and her life. From her earliest days as a Discovery Biologist, she has found her passion in work that tries to help people in need. She shares with us some stories about…

Read More

Donald Kirsch: Getting to Know a Drug Hunter

Dec 10, 2019

We’ve all been there. You are at a party and someone asks, “So, what do you do?” Dr. Kirsch always found it hard to explain his career as a discovery scientist. He decided to write a book about it.  The Drug Hunters: An Improbable Quest to Discover New Medicines is a colorful, fact-filled narrative history of…

Read More

Episode 3: Hope Can Be Curative.

Nov 18, 2019

David Pearce Ph.D., Sanford Research Leader Today we hear from David Pearce, PhD, President of Innovation and Research, Sanford Health and Vice Chair, Consortium Assembly, International Rare Disease Research Consortium (IRDiRC) Dr. Pearce’s rare disease background emanates from publishing over 100 research papers on Batten Disease. David talks to us about…

Read More

Episode 2: Kyle Bryant: Remember Why We Are Doing All This

Oct 9, 2019

We welcome Kyle Bryant of the Friedreich’s Ataxia Research Alliance (FARA) to discuss his journey as a patient with Friedreich’s Ataxia (FA), as an active patient leader, and in his job as a liaison between the FA community and researchers. After being diagnosed with FA when only 17 years old,…

Read More

Episode 1: David Fajgenbaum, MD, MBA, MSC, FCPP

Sep 25, 2019

Chasing My Cure: A Doctor’s Race to Turn Hope Into Action We are honored to have Dr. David Fajgenbaum as our first guest on Improbable Developments. His story is intense. Before he even earned is medical degree, he was faced by a rare life-threatening illness for which there was no…

Read More
Improbable Developments: The human stories behind the medicines

Welcome to Improbable Developments!

Sep 1, 2019

In this, our first episode, Kevin lays out the objectives and plan for the Improbable Developments podcast. He also shares a personal story about a medicine he worked on earlier in his career.

Read More

News & Publications

But what does it mean to educate a patient?

By Heather McCullen | Apr 30, 2019

Many individuals and organizations, including Salem Oaks, talk about patient education and health literacy. But what does it mean to educate a patient? Is the opposite of an educated patient an uneducated patient? Last month Salem Oaks presented a panel discussionat Patients as Partnersin Philadelphia. The objective of the session was to…

Read More

UPDATE: Online Course Library Grows

By Kevin Freiert | Apr 26, 2019

Salem Oaks’ portfolio of online courses is growing rapidly. Since last month, we launched two new modules in the R&D decision-making series, bringing the total to four. Check them out and see where we are going next!

Read More

Final Installment of Open Water Sets Sail

By Kevin Freiert | Apr 15, 2019

The fourth module in our series on Decision Making in Pharmaceutical Research and Development. focuses on the decisions required for Phase 1 Clinical Studies. The stakes are higher as people participate in the studies. These first studies establish a beachhead that will allow the team to learn more and more about the compound. It gets pretty exciting!

Read More

Open Water Part 2: Discovery and Pre-Clinical Research

By Kevin Freiert | Apr 5, 2019

Salem Oaks is proud to launch the third module in our series on Decision Making in Pharmaceutical Research and Development.  The underlying goal of this series is to help equip you to be part of a Research and Development Team.   The first module, Decisions Decisions, gave a high-level overview of…

Read More

Resources are Great, But…

By Jamie Roger | Apr 3, 2019

Resources are great.  But what if you don’t know that they exist, or where to find them? Patient foundations are an invaluable collection of resources for their respective patient groups. They offer support, various libraries of information and disease facts, resources (financial, medical, community oriented, mental health services, etc.) and,…

Read More

Open Water: Selecting a Research Project

By Kevin Freiert | Mar 25, 2019

The second module in our series on Decision Making in Pharmaceutical Research and Development will dive a little deeper into the decisions about selection, funding, and support for Research Projects. The underlying goal of our new course is to help equip you to be an effective part of a Research Team. Are you ready?

Read More

Bringing Hope to Patients as Partners

By Kevin Freiert | Mar 16, 2019

At Patients as Partners, our panel spoke about HOPE and asked the audience to think about a few questions.
–What is the power of hope?
–How much is hope worth?
–How much value do you create each time you give or receive hope?

Read More

Confidence is Key By Guest Author Dillon Head

By Jamie Roger | Jan 22, 2019

In life, you’re given a gift; confidence. What you do with that gift is up to you and only you. In my life I have also been given a few other “gifts” that I didn’t ask for, opened, and now I have to deal with them. At age 15 or…

Read More